Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.920
-0.110 (-3.63%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $211.17 million as of August 28, 2026. Its market cap has increased by 150.80% in one year.
Market Cap
211.17M
Enterprise Value
132.62M
1-Year Change
150.80%
Ranking
Category
Stock Price
$2.92
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $211.17M, a decrease of -65.85%. That is a compound annual growth rate of -18.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 211.17M | 65.22% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |
| Precision BioSciences | 214.74M |
| NovaBridge Biosciences | 213.44M |
| PepGen | 213.32M |
| Corbus Pharmaceuticals Holdings | 211.01M |
| AN2 Therapeutics | 210.57M |
| Immunic | 210.12M |